tirzepatide heart failure fda Lilly Withdraws Application to for Does Tirzepatide Shrink Your Heart?
Description
No overall differences in safety or effectiveness of ZEPBOUND have been observed between patients 65 years of age and older and younger adult patients
4.10 SURMOUNT-1: tirzepatide for weight loss in obese adults In the SURMOUNT-1 trial, 2,539 adults with an average weight of 104.8 kg and an average BMI of 38.0 were treated with weekly doses of tirzepatide (5 mg, 10 mg, 15 mg) or placebo for 72 weeks
Maybe abdominal injections cause more anxiety-related symptoms
body weight 112.7 kg [24.8]) [20], compared with SURMOUNT-1 as used in the NMA (mean [SD] waist circumference 114.1 cm [15.2]
To my knowledge, I do not have gastroparesis but you may have seen that it is a known potential side effect for GLP-1RAs
